Advertisement

Ads Placeholder
Loading...

Genus plc

GENSF•PNK
Healthcare
Biotechnology
$33.15
$-2.82(-7.83%)
U.S. Market opens in 5h 2m

Genus plc (GENSF) Stock Overview

Explore Genus plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio34.33
EPS (TTM)$0.94
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$33.99
3 Months$41.25
1 Year Target$39.85

GENSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genus plc (GENSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 19.60, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $39.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.33 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.81%
5-Day Change
-7.83%
1-Month Change
-10.99%
3-Month Change
-5.27%
6-Month Change
-5.68%
Year-to-Date (YTD) Change
-5.27%
1-Year Change
32.09%
3-Year Change
-5.62%
5-Year Change
-52.23%
All-Time (Max) Change
1557.75%

Contact Information

https://www.genusplc.com
44 1256 347 100
Matrix House, Basingstoke, NaN, RG21 4DZ

Company Facts

35,000 Employees
IPO DateSep 11, 2009
CountryGB
Actively Trading

Frequently Asked Questions